The shares of Mid-Cap firm, specializing in offering digital funds and monetary companies, are in focus upon a Bulk Deal Involving Goldman Sachs and Antfin Netherlands Holding.
With a market capitalization of Rs. 53,380.19 crores on Wednesday, the shares of One 97 Communications Ltd declined by upto 3.1 p.c, making a low of Rs. 829.15 per share in comparison with its earlier closing worth of Rs. 856.55 per share.
One 97 Communications Ltd, engaged in offering digital funds and monetary companies, lately skilled a bulk deal during which Goldman Sachs (Singapore) Pte purchased 37.35 lakh fairness shares, at Rs. 823.1 per share for Rs. 307.4 crore, representing a complete of 0.59 p.c of the corporate.
Together with it, Antfin Netherlands Holding BV has offloaded 1.27 crore fairness shares, at Rs. 826.04 per share for Rs. 1,053.6 crore and one other 1.27 crore fairness shares, at Rs. 823.30 per share for Rs. 1,050.1 crore, representing a complete of 4 p.c of the corporate.
This important stake buy and sale by outstanding institutional traders has caught the market’s consideration, elevating questions in regards to the inventory’s near-term outlook. The transfer comes amid elevated volatility in shares, prompting retail traders to carefully monitor the scenario.
Financials & others
The corporate’s income declined by 10.9 p.c from Rs. 2,398.8 crore to Rs. 2,135.3 crore in Q4FY24-25. In the meantime, Web loss declined from a lack of Rs. 549.6 crore to a lack of Rs. 539.8 crore throughout the identical interval. The corporate has a low debt-to-equity ratio of 0.01. It has achieved a powerful 26.12 p.c common income development during the last three years.
As of March 2025, the shareholding sample of One97 Communications Restricted reveals that promoters maintain no stake within the firm. International Institutional Buyers (FIIs) personal the most important share at 55.39 p.c, adopted by Home Institutional Buyers with 14.02 p.c. The remaining 30.60 p.c is held by retail traders.
Written by Sridhar J
Disclaimer

The views and funding ideas expressed by funding specialists/broking homes/score companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of monetary losses. Buyers should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer are usually not chargeable for any losses induced on account of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
